Navigation Links
Orsi Awarded First Place for Procedure with Embozene(TM) Microspheres
Date:1/19/2010

ATLANTA, Jan. 19 /PRNewswire/ -- Professor Franco Orsi, MD, Medical Director of the Unit of Interventional Radiology at the European Institute of Oncology was awarded The Symposium on Clinical Interventional Oncology 2010 Best Poster Award by Dr. Shaun Samuels, Lead Course Director, for his poster presentation entitled; Micro-Bland Embolization Combined with Radiofrequency Ablation for Treating Complex Hepatic Tumors.

Orsi's poster as well as an oral abstract, were presented to a capacity audience at this year's Pre-ISET Course, Clinical Interventional Cardiology (CIO), in Hollywood, Florida.  

In 18 patients affected by single unresectable liver tumors or unwilling to be resected, Orsi used a combination therapy of radiofrequency ablation (RFA) immediately after micro-bland transhepatic arterial embolization (MBTAE).   The technique pioneered by Orsi and the group at the European Institute of Oncology has demonstrated precise and ample tumor control.  During the procedure 40 and/or 100 micron Embozene Microspheres are used to block the micro vessels that supply blood to the tumors causing an additional reduction in tumor size by eliminating the blood supply and thermal dispersion.  Orsi's team then follows this with RFA.  In this combined procedure, the use of Embozene Microspheres has proven to increase the success and overcome previous limitations associated with RFA.

Orsi went on to state that technical success was achieved in all patients, with excellent results. All patients are alive and all tumor volumes have decreased within very safe margins.  Orsi's poster concluded to state that MBTAE has been carried out only with very small micro-spheres in order to induce a deep parenchymal ischemia for enhancing the thermal effect by RFA.  Combined therapy, in our series, has improved local results, allowing for a radical ablation of the so called "complex liver lesions". However, the series is limited and further prospective studies are needed for validating the combined approach.  

About Embozene Microspheres: Embozene Microspheres are the only microspheres offering 10 tightly calibrated sizes, each color-enhanced with a different color for increased procedural safety. They are composed of a hydrogel core and an exterior shell of Polyzene®-F, CeloNova's proprietary polymer which is proven to be anti-inflammatory and bacterial-resistant. Embozene Microspheres have been approved by the FDA for the treatment of hypervascular tumors and arteriovenous malformations. The 75, 1100, and 1300 micron sizes are not yet available in the US.

About CeloNova BioSciences: CeloNova develops novel medical devices that are enhanced by one of the Company's proprietary materials, Polyzene®-F, a lubricious, anti-thrombotic, anti-inflammatory, and bacterial-resistant surface treatment. The Company's current products include Embozene™ Color-Advanced Microspheres and the CATANIA™ Coronary Stent System with NanoThin Polyzene®-F. Both products are CE Marked. For more information, visit www.celonova.com.

SOURCE CeloNova BioSciences

RELATED LINKS
http://www.celonova.com

'/>"/>

SOURCE CeloNova BioSciences
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. €1.6 million ($2.32 million) grant awarded to Prof. Kobi Rosenblum for brain and memory research
2. Mimotopes Awarded a Major Peptide Library Supply Agreement by La Jolla Institute for their Studies Screening Dengue and Tuberculosis Pathogens
3. TeamStaff Awarded $3.3 Million Contract
4. pcRUSH.com / Atman, Inc. is Awarded General Services Administration (GSA) Schedule (GS-35F-0099W)
5. $12 Million American Recovery and Reinvestment Act Grant Awarded to Urban Health Plan, Inc. (UHP)
6. Jefferson awarded multi-million dollar NIH grant
7. Drummond Group Awarded DOE Funds for Texas Wind Integration Project
8. Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval
9. UM Clinical Research Building awarded prestigious LEED Building Certification
10. Turkey Genome Sequencing Consortium awarded $0.9 million from USDA
11. Acclaimed American Journalist Awarded Excellence In Journalism by American Society of Tropical Medicine and Hygiene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
Breaking Medicine Technology: